Polyphosphate: An ancient molecule that links platelets, coagulation, and inflammation

Blood

Volumn 119, Issue 25, 2012, Pages 5972-5979

  Morrissey, James H ^a   Choi, Sharon H ^a   Smith, Stephanie A ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 11; FIBRIN; HEPARIN; INDUSTRIAL CHEMICAL; POLYPHOSPHATE; THROMBIN;

BLOOD CLOTTING; DICTYOSTELIUM DISCOIDEUM; ESCHERICHIA COLI; HEART INFARCTION; HEMOSTASIS; HUMAN; INFLAMMATION; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; REVIEW; SIGNAL TRANSDUCTION; THROMBOCYTE; THROMBOSIS; TRYPANOSOMA BRUCEI;

EID: 84862729665     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-03-306605     Document Type: Review

References (114)

1. Ault-Riché D, Fraley CD, Tzeng CM, Kornberg A. Novel assay reveals multiple pathways regulating stress-induced accumulations of inorganic polyphosphate in Escherichia coli. J Bacteriol. 1998;180(7):1841-1847. (Pubitemid 28173065)
2. Brown MR, Kornberg A. Inorganic polyphosphate in the origin and survival of species. Proc Natl Acad Sci U S A. 2004;101(46):16085-16087. (Pubitemid 39552802)
3. Kornberg A, Rao NN, Ault-Riché D. Inorganic polyphosphate: a molecule of many functions. Annu Rev Biochem. 1999;68:89-125. (Pubitemid 29449188)
4. Lorenz B, Schröder HC. Mammalian intestinal alkaline phosphatase acts as highly active exopolyphosphatase. Biochim Biophys Acta. 2001;1547(2):254-261. (Pubitemid 32532143)
5. Smith SA, Mutch NJ, Baskar D, Rohloff P, Docampo R, Morrissey JH. Polyphosphate modulates blood coagulation and fibrinolysis. Proc Natl Acad Sci U S A. 2006;103(4):903-908. (Pubitemid 43212194)
6. Lorenz B, Leuck J, Kohl D, Muller WE, Schröder HC. Anti-HIV-1 activity of inorganic polyphosphates. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(2):110-118.
7. Pisoni RL, Lindley ER. Incorporation of [32P]orthophosphate into long chains of inorganic polyphosphate within lysosomes of human fibroblasts. J Biol Chem. 1992;267(6):3626-3631.
8. Ruiz FA, Lea CR, Oldfield E, Docampo R. Human platelet-dense granules contain polyphosphate and are similar to acidocalcisomes of bacteria and unicellular eukaryotes. J Biol Chem. 2004;279(43):44250-44257. (Pubitemid 39430828)
9. Kornberg A. Inorganic polyphosphate: toward making a forgotten polymer unforgettable. J Bacteriol. 1995;177(3):491-496.
10. Reusch RN, Huang R, Kosk-Kosicka D. Novel components and enzymatic activities of the human erythrocyte plasma membrane calcium pump. FEBS Lett. 1997;412(3):592-596. (Pubitemid 27337116)
11. Reusch RN. Transmembrane ion transport by polyphosphate/poly-(R)-3- hydroxybutyrate complexes. Biochemistry (Mosc). 2000;65(3):280-295.
12. Kawazoe Y, Katoh S, Onodera Y, Kohgo T, Shindoh M, Shiba T. Activation of the FGF signaling pathway and subsequent induction of mesenchymal stem cell differentiation by inorganic polyphosphate. Int J Biol Sci. 2008;4(1):37-47. (Pubitemid 351302798)
13. Jimenez-Nunez MD, Moreno-Sanchez D, Hernandez-Ruiz L, et al. Myeloma cells contain high inorganic polyphosphate levels that are associated with nucleolar transcription [published online ahead of print February 7, 2012]. Haematologica. doi:10.3324/haematol.2011.051409.
14. Wang L, Fraley CD, Faridi J, Kornberg A, Roth RA. Inorganic polyphosphate stimulates mammalian TOR, a kinase involved in the proliferation of mammary cancer cells. Proc Natl Acad Sci U S A. 2003;100(20):11249-11254. (Pubitemid 37205921)
15. Han KY, Hong BS, Yoon YJ, et al. Polyphosphate blocks tumour metastasis via anti-angiogenic activity. Biochem J. 2007;406(1):49-55. (Pubitemid 47264734)
16. Hernandez-Ruiz L, Gonzalez-Garcia I, Castro C, Brieva JA, Ruiz FA. Inorganic polyphosphate and specific induction of apoptosis in human plasma cells. Haematologica. 2006;91(9):1180-1186. (Pubitemid 44408427)
17. Kawazoe Y, Shiba T, Nakamura R, et al. Induction of calcification in MC3T3-E1 cells by inorganic polyphosphate. J Dent Res. 2004;83(8):613-618. (Pubitemid 41766069)
18. Schroder HC, Kurz L, Muller WE, Lorenz B. Polyphosphate in bone. Biochemistry (Mosc). 2000;65(3):296-303.
19. Leyhausen G, Lorenz B, Zhu H, et al. Inorganic polyphosphate in human osteoblast-like cells. J Bone Miner Res. 1998;13(5):803-812. (Pubitemid 28224196)
20. Pavlov E, Aschar-Sobbi R, Campanella M, Turner RJ, Gomez-Garcia MR, Abramov AY. Inorganic polyphosphate and energy metabolism in mammalian cells. J Biol Chem. 2010;285(13):9420-9428.
21. Galasso A, Zollo M. The Nm23-H1-h-Prune complex in cellular physiology: a 'tip of the iceberg' protein network perspective. Mol Cell Biochem. 2009;329(1):149-159.
22. Tammenkoski M, Koivula K, Cusanelli E, et al. Human metastasis regulator protein H-prune is a short-chain exopolyphosphatase. Biochemistry. 2008;47(36):9707-9713.
23. Smith SA, Morrissey JH. Polyphosphate as a general procoagulant agent. J Thromb Haemost. 2008;6(10):1750-1756.
24. Smith SA, Morrissey JH. Polyphosphate enhances fibrin clot structure. Blood. 2008;112(7):2810-2816.
25. Müller F, Mutch NJ, Schenk WA, et al. Platelet polyphosphates are proinflammatory and procoagulant mediators in vivo. Cell. 2009;139(6):1143-1156.
26. Mutch NJ, Myles T, Leung LL, Morrissey JH. Polyphosphate binds with high affinity to exosite II of thrombin. J Thromb Haemost. 2010;8(3):548-555.
27. Smith SA, Choi SH, Davis-Harrison R, et al. Polyphosphate exerts differential effects on blood clotting, depending on polymer size. Blood. 2010;116(20):4353-4359.
28. Semeraro F, Ammollo CT, Morrissey JH, et al. Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4. Blood. 2011;118(7):1952-1961.
29. Choi SH, Smith SA, Morrissey JH. Polyphosphate is a cofactor for the activation of factor XI by thrombin. Blood. 2011;118(26):6963-6970.
30. Mutch NJ, Engel R, Uitte de Willige S, Philippou H, Ariens RA. Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPAand plasminogen to fibrin. Blood. 2010;115(19):3980- 3988.
31. Docampo R, Moreno SN. Acidocalcisomes. Cell Calcium. 2011;50(2):113-119.
32. Noegel A, Gotschlich EC. Isolation of a high molecular weight polyphosphate from Neisseria gonorrhoeae. J Exp Med. 1983;157(6):2049-2060. (Pubitemid 13060902)
33. Tinsley CR, Manjula BN, Gotschlich EC. Purification and characterization of polyphosphate kinase from Neisseria meningitidis. Infect Immun. 1993;61(9):3703-3710. (Pubitemid 23260040)
34. Rao NN, Kornberg A. Inorganic polyphosphate supports resistance and survival of stationaryphase Escherichia coli. J Bacteriol. 1996;178(5):1394- 1400.
35. Kim KS, Rao NN, Fraley CD, Kornberg A. Inorganic polyphosphate is essential for long-term survival and virulence factors in Shigella and Salmonella spp. Proc Natl Acad Sci U S A. 2002;99(11):7675-7680. (Pubitemid 34568750)
36. Fraley CD, Rashid MH, Lee SS, et al. A polyphosphate kinase 1 (ppk1) mutant of Pseudomonas aeruginosa exhibits multiple ultrastructural and functional defects. Proc Natl Acad Sci U S A. 2007;104(9):3526-3531. (Pubitemid 46364192)
37. Li L, Rao NN, Kornberg A. Inorganic polyphosphate essential for lytic growth of phages P1 and fd. Proc Natl Acad Sci U S A. 2007;104(6):1794-1799. (Pubitemid 46239858)
38. Crooke E, Akiyama M, Rao NN, Kornberg A. Genetically altered levels of inorganic polyphosphate in Escherichia coli. J Biol Chem. 1994;269(9):6290-6295. (Pubitemid 24190996)
39. Zhang H, Rao NN, Shiba T, Kornberg A. Inorganic polyphosphate in the social life of Myxococcus xanthus: motility, development, and predation. Proc Natl Acad Sci U S A. 2005;102(38):13416-13420. (Pubitemid 41420862)
40. Shiba T, Tsutsumi K, Yano H, et al. Inorganic polyphosphate and the induction of rpoS expression. Proc Natl Acad Sci U S A. 1997;94(21):11210-11215. (Pubitemid 27450977)
41. Rashid MH, Rao NN, Kornberg A. Inorganic polyphosphate is required for motility of bacterial pathogens. J Bacteriol. 2000;182(1):225-227. (Pubitemid 30004581)
42. Rashid MH, Kornberg A. Inorganic polyphosphate is needed for swimming, swarming, and twitching motilities of Pseudomonas aeruginosa. Proc Natl Acad Sci U S A. 2000;97(9):4885-4890. (Pubitemid 30238652)
43. Zhang H, Ishige K, Kornberg A. A polyphosphate kinase (PPK2) widely conserved in bacteria. Proc Natl Acad Sci U S A. 2002;99(26):16678-16683. (Pubitemid 36034032)
44. Ishige K, Zhang H, Kornberg A. Polyphosphate kinase (PPK2), a potent, polyphosphate-driven generator of GTP. Proc Natl Acad Sci U S A. 2002;99(26):16684-16688. (Pubitemid 36034033)
45. Rao NN, Gomez-Garcia MR, Kornberg A. Inorganic polyphosphate: essential for growth and survival. Annu Rev Biochem. 2009;78:605-647.
46. Eichinger L, Pachebat JA, Glockner G, et al. The genome of the social amoeba Dictyostelium discoideum. Nature. 2005;435(7038):43-57. (Pubitemid 40655903)
47. Gomez-Garcia MR, Kornberg A. Formation of an actin-like filament concurrent with the enzymatic synthesis of inorganic polyphosphate. Proc Natl Acad Sci U S A. 2004;101(45):15876-15880. (Pubitemid 39507895)
48. Zhang H, Gomez-Garcia MR, Brown MR, Kornberg A. Inorganic polyphosphate in Dictyostelium discoideum: influence on development, sporulation, and predation. Proc Natl Acad Sci U S A. 2005;102(8):2731-2735. (Pubitemid 40299861)
49. Fang J, Rohloff P, Miranda K, Docampo R. Ablation of a small transmembrane protein of Trypanosoma brucei (TbVTC1) involved in the synthesis of polyphosphate alters acidocalcisome biogenesis and function, and leads to a cytokinesis defect. Biochem J. 2007;407(2):161-170. (Pubitemid 47556981)
50. Hothorn M, Neumann H, Lenherr ED, et al. Catalytic core of a membrane-associated eukaryotic polyphosphate polymerase. Science. 2009;324(5926):513-516.
51. Hermansky F, Pudlak P. Albinism associated with hemorrhagic diathesis and unusual pigmented reticular cells in the bone marrow: report of two cases with histochemical studies. Blood. 1959;14(2):162-169.
52. Holmsen H, Weiss HJ. Further evidence for a deficient storage pool of adenine nucleotides in platelets from some patients with thrombocytopathia: "storage pool disease." Blood. 1972;39(2):197-209.
53. Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood. 1987;70(3):620-623.
54. Dean GE, Fishkes H, Nelson PJ, Rudnick G. The hydrogen ion-pumping adenosine triphosphatase of platelet-dense granule membrane: differences from F1F0- and phosphoenzyme-type ATPases. J Biol Chem. 1984;259(15):9569-9574. (Pubitemid 14060521)
55. White JG. The dense bodies of human platelets: inherent electron opacity of the serotonin storage particles. Blood. 1969;33(4):598-606.
56. Fukami MH, Dangelmaier CA, Bauer JS, Holmsen H. Secretion, subcellular localization and metabolic status of inorganic pyrophosphate in human platelets: a major constituent of the amine-storing granules. Biochem J. 1980;192(1):99-105. (Pubitemid 11207914)
57. Hernández-Ruiz L, Saez-Benito A, Pujol-Moix N, Rodriguez-Martorell J, Ruiz FA. Platelet inorganic polyphosphate decreases in patients with delta storage pool disease. J Thromb Haemost. 2009;7(2):361-363.
58. Morrissey JH. Tissue factor: a key molecule in hemostatic and nonhemostatic systems. Int J Hematol. 2004;79(2):103-108. (Pubitemid 38281807)
59. Colman RW, Schmaier AH. Contact system: a vascular biology modulator with anticoagulant, profibrinolytic, antiadhesive, and proinflammatory attributes. Blood. 1997;90(10):3819-3843. (Pubitemid 27484034)
60. Colhoun HM, Zito F, Norman Chan N, Rubens MB, Fuller JH, Humphries SE. Activated factor XII levels and factor XII 46C>T genotype in relation to coronary artery calcification in patients with type 1 diabetes and healthy subjects. Atherosclerosis. 2002;163(2):363-369. (Pubitemid 34615828)
61. Grundt H, Nilsen DW, Hetland O, Valente E, Fagertun HE. Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarction. Am Heart J. 2004;147(2):260-266. (Pubitemid 38176826)
62. Doggen CJ, Rosendaal FR, Meijers JC. Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII. Blood. 2006;108(13):4045-4051. (Pubitemid 44913273)
63. Merlo C, Wuillemin WA, Redondo M, et al. Elevated levels of plasma prekallikrein, high molecular weight kininogen and factor XI in coronary heart disease. Atherosclerosis. 2002;161(2):261-267. (Pubitemid 34219178)
64. Salomon O, Steinberg DM, Koren-Morag N, Tanne D, Seligsohn U. Reduced incidence of ischemic stroke in patients with severe factor XI deficiency. Blood. 2008;111(8):4113-4117.
65. Gailani D, Renné T. Intrinsic pathway of coagulation and arterial thrombosis. Arterioscler Thromb Vasc Biol. 2007;27(12):2507-2513. (Pubitemid 350158899)
66. Müller F, Renné T. Novel roles for factor XIIdriven plasma contact activation system. Curr Opin Hematol. 2008;15(5):516-521.
67. Frick IM, Akesson P, Herwald H, et al. The contact system: a novel branch of innate immunity generating antibacterial peptides. EMBO J. 2006;25(23):5569-5578. (Pubitemid 44847197)
68. Ben Nasr A, Wistedt A, Ringdahl U, Sjöbring U. Streptokinase activates plasminogen bound to human group C and G streptococci through M-like proteins. Eur J Biochem. 1994;222(2):267-276. (Pubitemid 24204895)
69. Ben Nasr A, Olsen A, Sjöbring U, Müller-Esterl W, Bjorck L. Assembly of human contact phase proteins and release of bradykinin at the surface of curli-expressing Escherichia coli. Mol Microbiol. 1996;20(5):927-935. (Pubitemid 26198266)
70. Kalter ES, van Dijk WC, Timmerman A, Verhoef J, Bouma BN. Activation of purified human plasma prekallikrein triggered by cell wall fractions of Escherichia coli and Staphylococcus aureus. J Infect Dis. 1983;148(4):682-691. (Pubitemid 13021672)
71. Choi SH, Collins JN, Smith SA, Davis-Harrison RL, Rienstra CM, Morrissey JH. Phosphoramidate end labeling of inorganic polyphosphates: facile manipulation of polyphosphate for investigating and modulating its biological activities. Biochemistry. 2010;49(45):9935-9941.
72. Caen J, Wu Q. Hageman factor, platelets and polyphosphates: early history and recent connection. J Thromb Haemost. 2010;8(8):1670-1674.
73. Broze GJ Jr. Tissue factor pathway inhibitor and the current concept of blood coagulation. Blood Coagul Fibrinolysis. 1995;6(Suppl 1):S7-S13.
74. Mast AE, Broze GJ Jr. Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood. 1996;87(5):1845-1850. (Pubitemid 26068899)
75. Collen A, Smorenburg SM, Peters E, et al. Unfractionated and low molecular weight heparin affect fibrin structure and angiogenesis in vitro. Cancer Res. 2000;60(21):6196-6200.
76. Parise P, Morini M, Agnelli G, Ascani A, Nenci GG. Effects of low molecular weight heparins on fibrin polymerization and clot sensitivity to t-PA-induced lysis. Blood Coagul Fibrinolysis. 1993;4(5):721-727. (Pubitemid 23343395)
77. Nenci GG, Parise P, Morini M, Rossini A, Agnelli G. Fibrin clots obtained from plasma containing heparin show a higher sensitivity to t-PA-induced lysis. Blood Coagul Fibrinolysis. 1992;3(3):279-285.
78. Carr ME Jr, Cromartie R, Gabriel DA. Effect of homo poly(L-amino acids) on fibrin assembly: role of charge and molecular weight. Biochemistry. 1989;28(3):1384-1388. (Pubitemid 19058716)
79. Walsh PN, Gailani D. Factor XI. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:221-233.
80. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII: factor XI is activated by thrombin and factor XIa in the presence of negatively charged surfaces. J Biol Chem. 1991;266(12):7353- 7358. (Pubitemid 21906372)
81. Gailani D, Broze GJ Jr. Factor XI activation in a revised model of blood coagulation. Science. 1991;253(5022):909-912. (Pubitemid 21917236)
82. Gailani D, Broze GJ Jr. Factor XI.I-independent activation of factor XI in plasma: effects of sulfatides on tissue factor-induced coagulation. Blood. 1993;82(3):813-819. (Pubitemid 23221660)
83. Gailani D, Broze GJ Jr. Effects of glycosaminoglycans on factor XI activation by thrombin. Blood Coagul Fibrinolysis. 1993;4(1):15-20. (Pubitemid 23064910)
84. Pedicord DL, Seiffert D, Blat Y. Feedback activation of factor XI by thrombin does not occur in plasma. Proc Natl Acad Sci U S A. 2007;104(31):12855-12860. (Pubitemid 47255244)
85. Schmaier AH. Assembly, activation, and physiologic influence of the plasma kallikrein/kinin system. Int Immunopharmacol. 2008;8(2):161-165.
86. Asmis LM, Asmis R, Sulzer I, Furlan M, Lämmle B. Contact system activation in human sepsis: 47kD HK, a marker of sepsis severity? Swiss Med Wkly. 2008;138(9):142-149. (Pubitemid 351373910)
87. DeLa Cadena RA, Laskin KJ, Pixley RA, et al. Role of kallikrein-kinin system in pathogenesis of bacterial cell wall-induced inflammation. Am J Physiol. 1991;260(2):G213-G219.
88. DiScipio RG. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology. 1982;45(3):587-595. (Pubitemid 12165625)
89. Wiggins RC, Giclas PC, Henson PM. Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit. J Exp Med. 1981;153(6):1391-1404. (Pubitemid 11067627)
90. Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP. Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest. 1983;71(5):1450-1456. (Pubitemid 13098935)
91. Kishimoto TK, Viswanathan K, Ganguly T, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med. 2008;358(23):2457-2467. (Pubitemid 351793019)
92. Guerrini M, Beccati D, Shriver Z, et al. Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol. 2008;26(6):669-675. (Pubitemid 351824692)
93. Semeraro N, Ammollo CT, Semeraro F, Colucci M. Sepsis, thrombosis and organ dysfunction. Thromb Res. 2012;129(3):290-295.
94. Bae JS, Lee W, Rezaie AR. Polyphosphate elicits proinflammatory responses that are counteracted by activated protein C in both cellular and animal models [published online ahead of print February 28, 2012]. J Thromb Haemost. doi:10.1111/ j.1538-7836.2012.04671.x.
95. Kulakovskaya TV, Vagabov VM, Kulaev IS. Inorganic polyphosphate in industry, agriculture and medicine: odern state and outlook. Process Biochem. 2012;47(1):1-10.
96. Lorenz B, Schröder HC. Methods for investigation of inorganic polyphosphates and polyphosphatemetabolizing enzymes. Prog Mol Subcell Biol. 1999;23:217-239.
97. Clark JE, Wood HG. Preparation of standards and determination of sizes of long-chain polyphosphates by gel electrophoresis. Anal Biochem. 1987;161(2):280-290. (Pubitemid 17045976)
98. Kulaev IS, Vagabov VM, Kulakovskaya TV. The Biochemistry of Inorganic Polyphosphates (2nd Ed). Chichester, United Kingdom: John Wiley and Sons; 2004.
99. Smith SA, Morrissey JH. Sensitive fluorescence detection of polyphosphate in polyacrylamide gels using 4, 6-diamidino-2-phenylindol. Electrophoresis. 2007;28(19):3461-3465. (Pubitemid 47604706)
100. Kulakova AN, Hobbs D, Smithen M, et al. Direct quantification of inorganic polyphosphate in microbial cells using 4-6-diamidino-2-phenylindole (DAPI). Environ Sci Technol. 2011;45(18):7799-7803.
101. van Voorthuysen T, Regierer B, Springer F, Dijkema C, Vreugdenhil D, Kossmann J. Introduction of polyphosphate as a novel phosphate pool in the chloroplast of transgenic potato plants modifies carbohydrate partitioning. J Biotechnol. 2000;77(1):65-80. (Pubitemid 30058371)
102. Omelon S, Georgiou J, Henneman ZJ, et al. Control of vertebrate skeletal mineralization by polyphosphates. PLoS One. 2009;4(5):e5634.
103. Diaz JM, Ingall ED. Fluorometric quantification of natural inorganic polyphosphate. Environ Sci Technol. 2010;44(12):4665-4671.
104. Ramos IB, Miranda K, Ulrich P, et al. Calciumand polyphosphate-containing acidocalcisomes in chicken egg yolk. Biol Cell. 2010;102(7):421-434.
105. Aschar-Sobbi R, Abramov AY, Diao C, et al. High sensitivity, quantitative measurements of polyphosphate using a new DAPI-based approach. J Fluoresc. 2008;18(5):859-866.
106. Ohtomo R, Sekiguchi Y, Kojima T, Saito M. Different chain length specificity among three polyphosphate quantification methods. Anal Biochem. 2008;383(2):210-216.
107. Saito K, Ohtomo R, Kuga-Uetake Y, Aono T, Saito M. Direct labeling of polyphosphate at the ultrastructural level in Saccharomyces cerevisiae by using the affinity of the polyphosphate binding domain of Escherichia coli exopolyphosphatase. Appl Environ Microbiol. 2005;71(10):5692-5701. (Pubitemid 41456857)
108. Ramos IB, Miranda K, Pace DA, et al. Calciumand polyphosphate-containing acidic granules of sea urchin eggs are similar to acidocalcisomes, but are not the targets for NAADP. Biochem J. 2010;429(3):485-495.
109. Ramos I, Gomes F, Koeller CM, et al. Acidocalcisomes as calcium- and polyphosphate-storage compartments during embryogenesis of the insect Rhodnius prolixus Stahl. PLoS One. 2011;6(11):e27276.
110. Lorenz B, Marmé S,Müller WE, Unger K, Schröder HC. Preparation and use of polyphosphate-modified zirconia for purification of nucleic acids and proteins. Anal Biochem. 1994;216(1):118-126. (Pubitemid 24036841)
111. Ong SY, Wu J, Moochhala SM, Tan MH, Lu J. Development of a chitosan-based wound dressing with improved hemostatic and antimicrobial properties. Biomaterials. 2008;29(32):4323-4332.
112. Muhl L, Galuska SP, Oörni K, et al. High negative charge-to-size ratio in polyphosphates and heparin regulates factor VII-activating protease. FEBS J. 2009;276(17):4828-4839.
113. Ratnoff OD. Some relationships among hemostasis, fibrinolytic phenomena, immunity, and the inflammatory response. Adv Immunol. 1969;10:145-227.
114. Brown MR, Kornberg A. The long and short of it: polyphosphate, PPK and bacterial survival. Trends Biochem Sci. 2008;33(6):284-290.